Trending Topics in Gastroenterology
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
Introduction: Streptococcus anginosus has emerged as a microbial signature associated with gastric cancer, but the mechanism linking this bacterium to tumour progression has remained unclear. This study identifies...
Introduction: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most treatment-resistant cancers, with rapid recurrence and poor survival despite surgery and chemotherapy. This study identifies a novel molecular...
Introduction: Current antiviral therapies are generally virus-specific and vulnerable to viral mutations. Inspired by the success of mRNA vaccines, this study introduces Viral Protease-Initiated Lytic Cell Death (VIDA)—a...
The July 2026 Gut study on “A20 Protects Against Autoimmune Hepatitis” shows that A20 is a critical protective factor in autoimmune hepatitis (AIH) and helps prevent liver damage...
Introduction: Obstructive sleep apnea (OSA) is increasingly recognized as an important metabolic risk factor due to recurrent episodes of intermittent hypoxia (IH). Clinical studies have linked OSA with...
Introduction: Altered gut motility is increasingly recognized as a contributor to metabolic dysfunction through the gut–brain axis. Enterosynes are gut-derived bioactive molecules that regulate intestinal motility and influence...
Introduction: The gut microbiome and obesity are both known to influence cancer immunotherapy outcomes, yet the interaction between diet, obesity, and the microbiome has remained unclear. This landmark...
Introduction: Intrahepatic cholangiocarcinoma (ICC) is an aggressive primary liver cancer with poor prognosis and limited treatment options. While ICC has traditionally been considered a malignancy of biliary epithelial...
Introduction: Liver fibrosis is the key determinant of long-term outcomes in metabolic dysfunction-associated steatohepatitis (MASH). Activated hepatic stellate cells (HSCs) drive fibrogenesis, but effective antifibrotic therapies remain unavailable....
Introduction: The progression from metabolic dysfunction-associated fatty liver (MAFL) to metabolic dysfunction-associated steatohepatitis (MASH) is driven by complex interactions between hepatocytes and immune cells. This study identifies a...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.